What does DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE do?

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is a specialist medical practice in Evergem. Private Limited, started on 14 August 2001, 1 establishment.

What is the address of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

The registered office of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is located at Kluizendorpstraat 39, 9940 Evergem.

Is DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE still active?

Yes. According to the CBE (31 October 2026) DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 14 August 2001.

Is DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE registered on Peppol?

No, DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is currently not registered on the Peppol network.

What is the enterprise number of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

The enterprise number of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is BE0475471927.

When was DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE founded?

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE was founded on 14 August 2001.

Who are the directors of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

According to the 2025 annual accounts, the directors of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE are: Koenraad De Praeter, Silvia Violeta Sosa Lopez.

Is DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 August 2001; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE make in 2025?

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE posted a profit after taxes of € 206,371 in financial year 2025.

What is the revenue of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

As a small company, DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 318,661.

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE (Private Limited)

Dossier DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE, printed on 31 October 2026 from databakkes.be/en/0475471927/dr-koen-de-praeter-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE from Evergem, company number BE0475471927, closed financial year 2025 with a result of € 206,371 after tax. For that financial year DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE recorded a gross margin of € 318,661 and equity of € 1 million. Compared with financial year 2024, the result moved from € 159,472 to € 206,371. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 13, 2026.

What it is worth Growing

€ 1 million

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 206,371

▲ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 152,350

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1 million.

People and assets in 2025

Wage cost

€ 19,906

▼ 59% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 27,929

▲ € 27,856 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 154,641

▼ 24% vs 2024

€ 24,118 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 4,924

▲ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,196

▲ 61% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 298,477 Gross margin 2022: € 298,477 First fiscal year in the series	€ 246,028 Gross margin 2023: € 246,028 ▼ 18% vs 2022 (€ 298,477) Unfavourable step	€ 300,615 Gross margin 2024: € 300,615 ▲ 22% vs 2023 (€ 246,028) Favourable step	€ 318,661 Gross margin 2025: € 318,661 ▲ 6% vs 2024 (€ 300,615) Favourable step	▲ 6%
Profit after taxes	€ 152,806 Profit after taxes 2022: € 152,806 First fiscal year in the series	€ 117,780 Profit after taxes 2023: € 117,780 ▼ 23% vs 2022 (€ 152,806) Unfavourable step	€ 159,472 Profit after taxes 2024: € 159,472 ▲ 35% vs 2023 (€ 117,780) Favourable step	€ 206,371 Profit after taxes 2025: € 206,371 ▲ 29% vs 2024 (€ 159,472) Favourable step	▲ 29%
Equity	€ 872,730 Equity 2022: € 872,730 First fiscal year in the series	€ 655,510 Equity 2023: € 655,510 ▼ 25% vs 2022 (€ 872,730) Unfavourable step	€ 814,982 Equity 2024: € 814,982 ▲ 24% vs 2023 (€ 655,510) Favourable step	€ 1,021,353 Equity 2025: € 1,021,353 ▲ 25% vs 2024 (€ 814,982) Favourable step	▲ 25%
Total debts	€ 333,987 Total debts 2022: € 333,987 First fiscal year in the series	€ 604,537 Total debts 2023: € 604,537 ▲ 81% vs 2022 (€ 333,987) Unfavourable step	€ 227,189 Total debts 2024: € 227,189 ▼ 62% vs 2023 (€ 604,537) Favourable step	€ 192,441 Total debts 2025: € 192,441 ▼ 15% vs 2024 (€ 227,189) Favourable step	▼ 15%
Cash	€ 115,068 Cash 2022: € 115,068 First fiscal year in the series	€ 101,208 Cash 2023: € 101,208 ▼ 12% vs 2022 (€ 115,068) Unfavourable step	€ 144,600 Cash 2024: € 144,600 ▲ 43% vs 2023 (€ 101,208) Favourable step	€ 152,350 Cash 2025: € 152,350 ▲ 5% vs 2024 (€ 144,600) Favourable step	▲ 5%
Land & buildings	€ 734,414 Land & buildings 2022: € 734,414 First fiscal year in the series	€ 700,931 Land & buildings 2023: € 700,931 ▼ 5% vs 2022 (€ 734,414) Unchanged	€ 682,183 Land & buildings 2024: € 682,183 ▼ 3% vs 2023 (€ 700,931) Unchanged	€ 663,447 Land & buildings 2025: € 663,447 ▼ 3% vs 2024 (€ 682,183) Unchanged	▼ 3%
Retained profit	€ 860,330 Retained profit 2022: € 860,330 First fiscal year in the series	€ 643,110 Retained profit 2023: € 643,110 ▼ 25% vs 2022 (€ 860,330) Unfavourable step	€ 802,582 Retained profit 2024: € 802,582 ▲ 25% vs 2023 (€ 643,110) Favourable step	€ 1,008,953 Retained profit 2025: € 1,008,953 ▲ 26% vs 2024 (€ 802,582) Favourable step	▲ 26%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 335,000 Dividend 2023: € 335,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 335,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 313,648 Bank debt 2022: € 313,648 First fiscal year in the series	€ 259,056 Bank debt 2023: € 259,056 ▼ 17% vs 2022 (€ 313,648) Favourable step	€ 202,238 Bank debt 2024: € 202,238 ▼ 22% vs 2023 (€ 259,056) Favourable step	€ 154,641 Bank debt 2025: € 154,641 ▼ 24% vs 2024 (€ 202,238) Favourable step	▼ 24%
Balance sheet total	€ 1,206,718 Balance sheet total 2022: € 1,206,718 First fiscal year in the series	€ 1,260,047 Balance sheet total 2023: € 1,260,047 ▲ 4% vs 2022 (€ 1,206,718) Unchanged	€ 1,042,170 Balance sheet total 2024: € 1,042,170 ▼ 17% vs 2023 (€ 1,260,047) Unchanged	€ 1,213,794 Balance sheet total 2025: € 1,213,794 ▲ 16% vs 2024 (€ 1,042,170) Unchanged	▲ 16%

Key figures of DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

What happened at DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 13, 2026 New annual accounts for financial year 2025: profit of € 206,371 (▲ 29% vs 2024). filed late Source: NBB ↗
2023 Silvia Violeta Sosa Lopez became a director. NBB
2001 Koenraad De Praeter became a director. NBB
Aug 14, 2001 Start of the company according to the CBE. KBO
Aug 1, 2001 New establishment in Evergem. KBO

In short

From € 152,806 profit in 2022 to € 206,371 profit in 2025.

Paid € 278,006 in corporate taxes since 2022.

Best year ever: 2025, with € 206,371 profit.

Paid out € 335,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Koenraad De Praeter Silvia Violeta Sosa Lopez

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE

Behind DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE are Koenraad De Praeter and Silvia Violeta Sosa Lopez.

Directors

According to the 2025 annual accounts

Koenraad De Praeter

Director

since 2001

Silvia Violeta Sosa Lopez

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Kluizendorpstraat 39

9940 Evergem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0475.471.927

VAT number

BE 0475.471.927

Registered office

Kluizendorpstraat 39, 9940 Evergem

Names & denominations

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

14 August 2001

Peppol

Not registered

Contact

users.telenet.be [email protected] 093573582

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE

Warning lights

Financials

What happened to DR. KOEN DE PRAETER, ALGEMENE GENEESKUNDE?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions